Guidelines for the diagnosis and management of asthma: a look at the key differences between BTS/SIGN and NICE

John White, James Y Paton, Robert Niven, Hilary Pinnock

10.1136/thoraxjnl-2017-211189

January 3, 2018

Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years

Surya P Bhatt, Young-il Kim, Kathy F Harrington, John E Hokanson, Sharon M Lutz, Michael H Cho, Dawn L DeMeo, James M Wells, Barry J Make, Stephen I Rennard, George R Washko, Marilyn G Foreman, Donald P Tashkin, Robert A Wise, Mark T Dransfield, William C Bailey

10.1136/thoraxjnl-2017-210722

January 11, 2018

Editor's choice

Airway responsiveness to methacholine and incidence of COPD: an international prospective cohort study

Alessandro Marcon, Francesca Locatelli, Dirk Keidel, Anna B Beckmeyer-Borowko, Isa Cerveri, Shyamali C Dharmage, Elaine Fuertes, Judith Garcia-Aymerich, Joachim Heinrich, Medea Imboden, Christer Janson, Ane Johannessen, Bénédicte Leynaert, Silvia Pascual Erquicia, Giancarlo Pesce, Emmanuel Schaffner, Cecilie Svanes, Isabel Urrutia, Deborah Jarvis, Nicole M Probst-Hensch, Simone Accordini, on behalf of the Ageing Lungs in European Cohorts (ALEC) study, Judith Garcia-aymerich, John Henderson, Nicole Probst-hensch, Cosetta Minelli, Marike Boezen, Bernice Elger, Bo Alexander Gleditsch, Bas Heijmans, Isabelle Romieu, John Thompson

10.1136/thoraxjnl-2017-211289

May 2, 2018

Home treatment of COPD exacerbation selected by DECAF score: a non-inferiority, randomised controlled trial and economic evaluation

Carlos Echevarria, Joanne Gray, Tom Hartley, John Steer, Jonathan Miller, A John Simpson, G John Gibson, Stephen C Bourke

10.1136/thoraxjnl-2017-211197

April 21, 2018

Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations

David Mayhew, Nathalie Devos, Christophe Lambert, James R Brown, Stuart C Clarke, Viktoriya L Kim, Michal Magid-Slav, Bruce E Miller, Kristoffer K Ostridge, Ruchi Patel, Ganesh Sathe, Daniel F Simola, Karl J Staples, Ruby Sung, Ruth Tal-Singer, Andrew C Tuck, Stephanie Van Horn, Vincent Weynants, Nicholas P Williams, Jeanne-Marie Devaster, Tom M A Wilkinson, on behalf of the AERIS Study Group, J Alnajar, R Anderson, E Aris, WR Ballou, A Barton, S Bourne, M Caubet, SC Clarke, D Cleary, C Cohet, N Coombs, K Cox, J-M Devaster, V Devine, N Devos, E Dineen, T Elliott, R Gladstone, S Harden, J Jefferies, V Kim, S Mesia Vela, P Moris, K Ostridge, TG Pascal, M Peeters, S Schoonbroodt, KJ Staples, A Tuck, L Welch, V Weynants, TMA Wilkinson, AP Williams, N Williams, C Woelk, M Wojtas, S Wootton

10.1136/thoraxjnl-2017-210408

January 31, 2018

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor

Leona Bessonova, Nataliya Volkova, Mark Higgins, Leif Bengtsson, Simon Tian, Christopher Simard, Michael W Konstan, Gregory S Sawicki, Ase Sewall, Stephen Nyangoma, Alexander Elbert, Bruce C Marshall, Diana Bilton

10.1136/thoraxjnl-2017-210394

May 10, 2018

Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England

Ramyani P Gupta, Mome Mukherjee, Aziz Sheikh, David P Strachan

10.1136/thoraxjnl-2017-210714

May 14, 2018

Mesenchymal stromal cells: a novel therapy for the treatment of chronic obstructive pulmonary disease?

Winifred Broekman, Padmini P S J Khedoe, Koen Schepers, Helene Roelofs, Jan Stolk, Pieter S Hiemstra

10.1136/thoraxjnl-2017-210672

April 13, 2018

Long-term treatment of patients with idiopathic pulmonary fibrosis with nintedanib: results from the TOMORROW trial and its open-label extension

Luca Richeldi, Michael Kreuter, Moisés Selman, Bruno Crestani, Anne-Marie Kirsten, Wim A Wuyts, Zuojun Xu, Katell Bernois, Susanne Stowasser, Manuel Quaresma, Ulrich Costabel

10.1136/thoraxjnl-2016-209701

October 9, 2017

Improving the global diagnosis and management of asthma in children

Warren Lenney, Andrew Bush, Dominic A Fitzgerald, Monica Fletcher, Anders Ostrem, Soren Pedersen, Stanley J Szefler, Heather J Zar, on behalf of the GSK Paediatric Project Advisory Board and Committee

10.1136/thoraxjnl-2018-211626

May 14, 2018